Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Return on Equity (2016 - 2025)

Fortress Biotech has reported Return on Equity over the past 13 years, most recently at 0.95% for Q4 2025.

  • Quarterly results put Return on Equity at 0.95% for Q4 2025, down 1707.0% from a year ago — trailing twelve months through Dec 2025 was 0.95% (down 1707.0% YoY), and the annual figure for FY2025 was 1.37%, down 424148.0%.
  • Return on Equity for Q4 2025 was 0.95% at Fortress Biotech, up from 1.47% in the prior quarter.
  • Over the last five years, Return on Equity for FBIO hit a ceiling of 106.18% in Q1 2024 and a floor of 112.75% in Q2 2023.
  • Median Return on Equity over the past 5 years was 0.89% (2021), compared with a mean of 1.95%.
  • Biggest five-year swings in Return on Equity: surged 12380bps in 2024 and later plummeted -11280bps in 2025.
  • Fortress Biotech's Return on Equity stood at 0.84% in 2021, then tumbled by -226bps to 2.75% in 2022, then soared by 1015bps to 25.18% in 2023, then tumbled by -36bps to 16.13% in 2024, then crashed by -106bps to 0.95% in 2025.
  • The last three reported values for Return on Equity were 0.95% (Q4 2025), 1.47% (Q3 2025), and 3.17% (Q2 2025) per Business Quant data.